Autonomous Therapeutics, Inc.

Autonomous Therapeutics, Inc. develops encrypted RNA-based therapeutics that are target-activated and variant-agnostic for treating diseases ranging from influenza to colon cancer. The company pioneers nucleic acid drug candidates designed to maintain efficacy across viral variants and disease targets.